In this webinar, Dr. Xiaoyu Zhu, Senior Business Development Manager at Creative BioMart, will introduce Creative BioMart’s integrated AI platform, which enables accurate 3D structure prediction, affinity maturation, immunogenicity risk assessment, and de novo antibody design — significantly reducing development time and cost. The session will cover our GMP-compliant facilities, scalable mammalian and microbial expression systems, and comprehensive quality control processes. Attendees will learn how our AI-first, dry-wet closed-loop approach achieves high success rates in antibody engineering and membrane protein production, supporting next-generation biotherapeutics.

The webinar is free to attend, but you need to sign up here or by clicking “Open resource”.